To the full analysis
Buyback calculator for Intco Medical Technology
Intco Medical Technology Stock: Key Metrics
300677.SZIntco Medical Technology had an operating margin of 12.4% and a return on invested capital (ROIC) of 6% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 20 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2013 | 14.9% | 3.9% | 1.5% |
| 2014 | 17.8% | 4.5% | 3.6% |
| 2015 | 26.4% | 7.9% | 6.4% |
| 2016 | 24.5% | 8.5% | 7.3% |
| 2017 | 24.8% | 9.6% | 8.3% |
| 2018 | 24.7% | 10.8% | 9.5% |
| 2019 | 25.0% | 9.7% | 8.6% |
| 2020 | 69.0% | 60.5% | 50.6% |
| 2021 | 61.4% | 53.5% | 45.8% |
| 2022 | 12.7% | 10.7% | 9.5% |
| 2023 | 13.6% | 6.3% | 5.5% |
| 2024 | 22.8% | 17.6% | 15.4% |
| 2025 | 24.1% | 12.4% | 10.2% |
Returns on Capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2013 | 7.3% | 8.9% | 1.5% |
| 2014 | 18.9% | 10.2% | 4.9% |
| 2015 | 15.5% | 15.8% | 8.5% |
| 2016 | 16.1% | 13.6% | 7.4% |
| 2017 | 13.3% | 16.5% | 8.7% |
| 2018 | 14.1% | 15.7% | 7.4% |
| 2019 | 12.1% | 12.4% | 6.0% |
| 2020 | 75.0% | 284.8% | 54.2% |
| 2021 | 46.8% | 131.5% | 36.0% |
| 2022 | 4.0% | 6.7% | 2.9% |
| 2023 | 2.4% | 3.5% | 1.4% |
| 2024 | 8.4% | 13.7% | 4.2% |
| 2025 | 5.5% | 6.0% | 2.5% |
Data and Required Disclosures
- ; time horizon around 12 months
- Rated Weak since 7 Nov 2026; valuation signal Fairly valued since 20 Nov 2026
- Price: closing price of 20 Nov 2026
- Amounts in US dollars at the ECB reference rate of 19 Nov 2026 ($1 = CN¥6.6667)
- Data from Financial Modeling Prep (FMP) based on the company's reports, latest fiscal year 2025. MEQIRI calculates the score and fair value itself every night.
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.
